Interrupted time-series analysis of the impact of generic market entry of antineoplastic products in China.

Our findings suggested that entry of generic drugs impacted use and cost of antineoplastic medicines in China. Generic drugs may improve the availability and the affordability of antineoplastic agents, which would benefit more patients.